Literature DB >> 16333175

Fulminate retinopathy of prematurity - clinical characteristics and laser outcome.

Parag K Shah1, V Narendran, V R Saravanan, A Raghuram, Abhijit Chattopadhyay, Maithreyi Kashyap, Rodney J Morris, N Vijay, V Raghuraman, Virna Shah.   

Abstract

PURPOSE: To analyse the clinical characteristics and treatment outcome of zone 1 Fulminate type of Retinopathy of Prematurity (ROP) and compare it to Conventional ROP.
METHODS: Preterm infants from two neonatal intensive care units (NICU) born between July 2002 and November 2003 were screened for ROP. Cases with Conventional ROP were classified according to the International Classification of Retinopathy of Prematurity (ICROP) while that of Fulminate ROP according to Shapiro's classification. Threshold disease was kept the cut off for treatment for Conventional ROP and stage 3A for Fulminate ROP.
RESULTS: Of the 54 cases that had treatable ROP, 36 (66.67%) had Fulminate type. The mean gestational age and birth weight was higher in Fulminate ROP compared to Conventional disease (31.75 weeks and 1554 gms vs 31 weeks 1387 gms) whereas the mean postnatal age at laser was lower (4.62 weeks vs 6.3 weeks). The average number of laser spots given was 3036.6 for Fulminate disease.
CONCLUSION: Fulminate ROP had an atypical morphology which was difficult to classify according to ICROP classification and we would like to lay stress upon the importance of screening of premature infants from the age of 4 weeks and to start treatment immediately once Fulminate ROP has been diagnosed.

Entities:  

Mesh:

Year:  2005        PMID: 16333175     DOI: 10.4103/0301-4738.18908

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  9 in total

1.  Retinopathy of Prematurity in a rural Neonatal Intensive Care Unit in South India--a prospective study.

Authors:  Bhavana Hungi; Anand Vinekar; Narendra Datti; Pushpalatha Kariyappa; Sherine Braganza; Susheela Chinnaiah; Krishnamurthy Donthi; Bhujang Shetty
Journal:  Indian J Pediatr       Date:  2012-02-23       Impact factor: 1.967

Review 2.  Retinopathy of prematurity: Past, present and future.

Authors:  Parag K Shah; Vishma Prabhu; Smita S Karandikar; Ratnesh Ranjan; Venkatapathy Narendran; Narendran Kalpana
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 3.  Aggressive posterior retinopathy of prematurity: a review on current understanding.

Authors:  Devesh Kumawat; Anusha Sachan; Pooja Shah; Rohan Chawla; Parijat Chandra
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

4.  Awareness of retinopathy of prematurity among pediatricians in a tier two city of South India.

Authors:  S R Sathiamohanraj; Parag K Shah; D Senthilkumar; V Narendran; N Kalpana
Journal:  Oman J Ophthalmol       Date:  2011-05

5.  Do we need India-specific retinopathy of prematurity screening guidelines?

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

6.  Prevalence, risk factors and pattern of severe retinopathy of prematurity in eastern Madhya Pradesh.

Authors:  Anamika Dwivedi; Deepak Dwivedi; Sujata Lakhtakia; Charudutt Chalisgaonkar; Shashi Jain
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

7.  Retinopathy of prematurity: a review of epidemiology and current treatment strategies.

Authors:  Eun Hee Hong; Yong Un Shin; Heeyoon Cho
Journal:  Clin Exp Pediatr       Date:  2021-10-12

8.  Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: ten year data from a tertiary care center in a developing country.

Authors:  Anand Vinekar; Mangat R Dogra; Tiakumzuk Sangtam; Anil Narang; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

9.  Enhancing Image Characteristics of Retinal Images of Aggressive Posterior Retinopathy of Prematurity Using a Novel Software, (RetiView).

Authors:  Chaitra Jayadev; Anand Vinekar; Poornima Mohanachandra; Samit Desai; Amit Suveer; Shwetha Mangalesh; Noel Bauer; Bhujang Shetty
Journal:  Biomed Res Int       Date:  2015-07-09       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.